(Q56935643)

5

Jaap Goudsmit

0 references

William A Paxton

6

William A. Paxton

0 references

Aletta Kliphuis

3

Aletta Kliphuis

0 references

Moustapha I. M. Chalaby

4

Moustapha I. M. Chalaby

0 references

author name string

Stanley Kang

Journal of Biological Chemistry

2

0 references

language of work or name

English

0 references

publication date

16 January 2001

0 references

published in

0 references

volume

276

0 references

issue

16

0 references

page(s)

13433-13441

0 references

cites work

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Relationship between productive HIV-1 infection of macrophages and CCR5 utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

HIV-1 envelope determinants for cell tropism and chemokine receptor use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Functional characterization of the V1V2 region of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Carbohydrate determinant NeuAc-Galbeta(1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

C-C chemokines, pivotal in protection against HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Association between CCR5 genotype and the clinical course of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200

Relation of phenotype evolution of HIV-1 to envelope V2 configuration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009779200